Speakers: Jay Shubrook, Robert Chilton
Disclosures
In the wake of the revised blood pressure targets, recommended by the American Diabetes Association's 2017 Position Statement and 2018 Standards of Care, Editorial Board member Jay Shubrook and Advisory Board member Robert Chilton discuss clinical approaches to get hypertensive diabetes patients to target more consistently (12:29).
Learning points include:
- The atherogenic risk posed by diabetes and why blood pressure measurements from the arm-alone may not be sufficient to evaluate the threat in all patients.
- The benefits and drawbacks of the medication classes indicated for hypertension treatment, such as:
- Diuretics
- β-blockers
- Calcium channel blockers
- The impact and rationale for targeting blood pressures lower than those indicated in the ADA position statement.
Video 3: When to intervene in patients with diabetes and high blood pressure? »